| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 79, 1655-1658, Copyright © 1994 by Endocrine Society
ARTICLES |
Y Imai, A Fusco, Y Suzuki, MA Lesniak, R D'Alfonso, G Sesti, A Bertoli, R Lauro, D Accili and SI Taylor
Diabetes Branch, National Institute of Diabetes and Digestive and Kidney Disease, National Institutes of Health, Bethesda, Maryland 20892.
The pathophysiology of noninsulin-dependent diabetes mellitus (NIDDM) is characterized by insulin resistance and insulin deficiency. To search for genetic defects causing NIDDM, we have screened for mutations in the gene encoding insulin receptor substrate-1 (IRS-1), an intracellular protein that is phosphorylated by the insulin receptor and is thought to play an important role in mediating insulin action. The coding sequence of the IRS-1 gene (divided into 12 overlapping fragments) was amplified by polymerase chain reaction and screened for the presence of single stranded conformational polymorphisms. This led to the identification of 6 variants in the nucleotide sequence. There were 3 nonconservative amino acids substitutions: Gly819-->Arg, Gly972-- >Arg, and Arg1221-->Cys. In addition, there were three silent polymorphisms: GAC vs. GAT encoding Asp90, GGG vs. GGA encoding Gly235, and GCA vs. GCG encoding Ala805. The previously reported Arg972 substitution was identified in 7 of 31 patients with NIDDM, 4 of 32 normal subjects, and 4 of 16 nondiabetic obese individuals. The 2 novel amino acid substitutions (Arg819 and Cys1221) were both detected in 1 patient with NIDDM, but not in either of the other 2 groups of nondiabetic individuals. All 3 amino acid residues are identically conserved in the amino acid sequences of human, mouse, and rat IRS-1, suggesting that Gly819, Gly972, and Arg1221 are important for the normal function of IRS-1. Furthermore, the prevalence of amino acid substitutions in IRS-1 is increased in patients with NIDDM. These observations suggest that mutations in the IRS-1 gene may play a causal role in the pathogenesis of NIDDM.
This article has been cited by other articles:
 |
|
 |
|
  F. Perticone, A. Sciacqua, A. Scozzafava, G. Ventura, E. Laratta, A. Pujia, M. Federici, R. Lauro, and G. Sesti Impaired Endothelial Function in Never-Treated Hypertensive Subjects Carrying the Arg972 Polymorphism in the Insulin Receptor Substrate-1 Gene J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3606 - 3609. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Sesti, M. A. Marini, M. Cardellini, A. Sciacqua, S. Frontoni, F. Andreozzi, C. Irace, D. Lauro, A. Gnasso, M. Federici, et al. The Arg972 Variant in Insulin Receptor Substrate-1 Is Associated With an Increased Risk of Secondary Failure to Sulfonylurea in Patients With Type 2 Diabetes Diabetes Care, June 1, 2004; 27(6): 1394 - 1398. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. N. Kulkarni, M. G. Roper, G. Dahlgren, D. Q. Shih, L. M. Kauri, J. L. Peters, M. Stoffel, and R. T. Kennedy Islet Secretory Defect in Insulin Receptor Substrate 1 Null Mice Is Linked With Reduced Calcium Signaling and Expression of Sarco(endo)plasmic Reticulum Ca2+-ATPase (SERCA)-2b and -3 Diabetes, June 1, 2004; 53(6): 1517 - 1525. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Marini, S. Frontoni, D. Mineo, D. Bracaglia, M. Cardellini, P. de Nicolais, A. Baroni, R. D'Alfonso, M. Perna, D. Lauro, et al. The Arg972 Variant in Insulin Receptor Substrate-1 Is Associated with an Atherogenic Profile in Offspring of Type 2 Diabetic Patients J. Clin. Endocrinol. Metab., July 1, 2003; 88(7): 3368 - 3371. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. L. Esposito, Y. Li, C. Vanni, S. Mammarella, S. Veschi, F. Della Loggia, R. Mariani-Costantini, P. Battista, M. J. Quon, and A. Cama A Novel T608R Missense Mutation in Insulin Receptor Substrate-1 Identified in a Subject with Type 2 Diabetes Impairs Metabolic Insulin Signaling J. Clin. Endocrinol. Metab., April 1, 2003; 88(4): 1468 - 1475. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Federici, A. Petrone, O. Porzio, C. Bizzarri, D. Lauro, R. D'Alfonso, I. Patera, M. Cappa, L. Nistico, M. Baroni, et al. The Gly972->Arg IRS-1 Variant Is Associated With Type 1 Diabetes in Continental Italy Diabetes, March 1, 2003; 52(3): 887 - 890. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. G. Laustsen, M. D. Michael, B. E. Crute, S. E. Cohen, K. Ueki, R. N. Kulkarni, S. R. Keller, G. E. Lienhard, and C. R. Kahn Lipoatrophic diabetes in Irs1-/-/Irs3-/- double knockout mice Genes & Dev., December 15, 2002; 16(24): 3213 - 3222. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Le Fur, C. Le Stunff, and P. Bougneres Increased Insulin Resistance in Obese Children Who Have Both 972 IRS-1 and 1057 IRS-2 Polymorphisms Diabetes, December 1, 2002; 51(90003): S304 - 307. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Sreekumar, P. Halvatsiotis, J. C. Schimke, and K. S. Nair Gene Expression Profile in Skeletal Muscle of Type 2 Diabetes and the Effect of Insulin Treatment Diabetes, June 1, 2002; 51(6): 1913 - 1920. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Marchetti, R. Lupi, M. Federici, L. Marselli, M. Masini, U. Boggi, S. Del Guerra, G. Patane, S. Piro, M. Anello, et al. Insulin Secretory Function Is Impaired in Isolated Human Islets Carrying the Gly972->Arg IRS-1 Polymorphism Diabetes, May 1, 2002; 51(5): 1419 - 1424. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M.N. Bezerra, V. de Castro, T. Sales, R. Passini Jr, S. T.M. Marba, S. T.O. Saad, and M. J.A. Saad The Gly972Arg Polymorphism in Insulin Receptor Substrate-1 Is Associated With Decreased Birth Weight in a Population-Based Sample of Brazilian Newborns Diabetes Care, March 1, 2002; 25(3): 550 - 553. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Pratipanawatr, T. Pratipanawatr, K. Cusi, R. Berria, J. M. Adams, C. P. Jenkinson, K. Maezono, R. A. DeFronzo, and L. J. Mandarino Skeletal Muscle Insulin Resistance in Normoglycemic Subjects With a Strong Family History of Type 2 Diabetes Is Associated With Decreased Insulin-Stimulated Insulin Receptor Substrate-1 Tyrosine Phosphorylation Diabetes, November 1, 2001; 50(11): 2572 - 2578. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. SESTI, M. FEDERICI, M. L. HRIBAL, D. LAURO, P. SBRACCIA, and R. LAURO Defects of the insulin receptor substrate (IRS) system in human metabolic disorders FASEB J, October 1, 2001; 15(12): 2099 - 2111. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Akune, N. Ogata, A. Seichi, I. Ohnishi, K. Nakamura, H. Kawaguchi, S. L. Mayers, and W. D. Spotnitz Insulin Secretory Response Is Positively Associated with the Extent of Ossification of the Posterior Longitudinal Ligament of the Spine J. Bone Joint Surg. Am., October 1, 2001; 83(10): 1537 - 1544. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. L. Esposito, Y. Li, A. Cama, and M. J. Quon Tyr612 and Tyr632 in Human Insulin Receptor Substrate-1 Are Important for Full Activation of Insulin-Stimulated Phosphatidylinositol 3-Kinase Activity and Translocation of GLUT4 in Adipose Cells Endocrinology, July 1, 2001; 142(7): 2833 - 2840. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Stumvoll, A. Fritsche, A. Volk, N. Stefan, A. Madaus, E. Maerker, A. Teigeler, M. Koch, F. Machicao, and H. Häring The Gly972Arg Polymorphism in the Insulin Receptor Substrate-1 Gene Contributes to the Variation in insulin Secretion in Normal Glucose-Tolerant Humans Diabetes, April 1, 2001; 50(4): 882 - 885. [Abstract] [Full Text]
|
|
|
|
|
|
M. L. Hribal, M. Federici, O. Porzio, D. Lauro, P. Borboni, D. Accili, R. Lauro, and G. Sesti The Gly->Arg972 Amino Acid Polymorphism in Insulin Receptor Substrate-1 Affects Glucose Metabolism in Skeletal Muscle Cells J. Clin. Endocrinol. Metab., May 1, 2000; 85(5): 2004 - 2013. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. G. Baroni, M. P. D’Andrea, A. Montali, G. Pannitteri, F. Barilla, F. Campagna, E. Mazzei, S. Lovari, F. Seccareccia, P. P. Campa, et al. A Common Mutation of the Insulin Receptor Substrate-1 Gene Is A Risk Factor for Coronary Artery Disease Arterioscler Thromb Vasc Biol, December 1, 1999; 19(12): 2975 - 2980. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. T. Solow, S. Harada, B. J. Goldstein, J. A. Smith, M. F. White, and L. Jarett Differential Modulation of the Tyrosine Phosphorylation State of the Insulin Receptor by IRS (Insulin Receptor Subunit) Proteins Mol. Endocrinol., October 1, 1999; 13(10): 1784 - 1798. [Abstract] [Full Text]
|
|
|
|
|
|
Y. Imai, N. Philippe, G. Sesti, D. Accili, and S. I. Taylor Expression of Variant Forms of Insulin Receptor Substrate-1 Identified in Patients with Noninsulin-Dependent Diabetes Mellitus J. Clin. Endocrinol. Metab., December 1, 1997; 82(12): 4201 - 4207. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
